Clinical Trial Detail

NCT ID NCT02997176
Title An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Medivation, Inc.
Indications

Advanced Solid Tumor

Therapies

Talazoparib

Age Groups: adult senior

No variant requirements are available.